A Novel Role for Cadherin-11
Total Page:16
File Type:pdf, Size:1020Kb
Mechanobiology of Cardiac Disease and Fibrosis: a Novel Role for Cadherin-11 By Alison Koelle Schroer Dissertation Submitted to the Faculty of the Graduate School of Vanderbilt University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in Biomedical Engineering December, 2016 Nashville, Tennessee Approved: W. David Merryman, Ph.D. John Wikswo, Ph.D. Michael Miga, Ph.D. Jeffrey Davidson, Ph.D. Antonis Hatzopoulos, Ph.D. Copyright © 2016 by Alison K Schroer All Rights Reserved ii ACKNOWLEDGEMENTS The heart has its reasons, of which reason knows nothing - Pascal I must acknowledge my coauthors on the manuscripts which have been adapted and included in this dissertation. First and foremost, my advisor Dave Merryman. Also Larisa Rhyzhova, Cyndi Clark, Hind Lal, Qinkun Zhang, Tom Force, John Wikswo, Veniamin Sidorov, Matthew Shotwell, Annabelle Manalo, and David Bader. I would also acknowledge Josh Bender and Claire Lafferty, undergraduate research assistants who assisted in the collection of some of the data included in this work. I would also like to acknowledge Meghan Bowler, Mark Vander Roest, Caleb Snider, Allison Price, and Jeffrey Davidson for their editorial comments on the work included in this dissertation. I would like to acknowledge my funding sources, especially the NSF and the AHA. Also, the ever wonderful Merryman Lab, members both past and present, who have been my comrades and friends throughout the last five years. Finally, I must acknowledge my family, my friends, and my God, without whom I never could have done all this. Keep your heart with all vigilance, for from it flow the springs of life. - Proverbs 4:23 iii TABLE OF CONTENTS Page ACKNOWLEDGEMENTS ............................................................................................... iii LIST OF TABLES ............................................................................................................ vi LIST OF FIGURES ......................................................................................................... vii CHAPTER 1. Introduction and Motivation ......................................................................................... 1 2. Background: Myocardial Development and Disease ................................................... 8 Mechanobiology of cardiac development.................................................................. 8 Cellular players in fibrotic cardiac disease, parallels with valve disease ................ 10 Etiology of cardiac fibrotic disease ......................................................................... 15 3. Background: Fibroblast Mechanobiology .................................................................. 21 Myofibroblast differentiation in response to mechanical stress ............................... 21 Integrins sense mechanical signals from the ECM ................................................. 28 Cadherins sense intercellular forces ....................................................................... 33 4. Aim 1: Elucidating Mechanosensitive Signaling Crosstalk in Fibroblasts .................. 39 Introduction ............................................................................................................. 39 Methods ................................................................................................................. 45 Results .................................................................................................................... 47 Discussion ............................................................................................................. 56 5. Aim 2: Cadherin-11 Exacerbates Tissue Remodeling after Myocardial Infarction ..... 62 Introduction ............................................................................................................. 62 Methods ................................................................................................................. 63 Results .................................................................................................................... 71 Discussion .............................................................................................................. 93 iv 6. Aim 3: Quantifying Cardiomyocyte Mechanics ........................................................ 105 Introduction to cardiomyocytes and motivation for study ...................................... 105 CENP-F mutation alters cardiac cell structure and mechanics ............................. 106 Introduction to engineered cardiac tissue constructs ............................................ 113 Methods of I-wire development and analysis ........................................................ 116 Results of I-wire analysis ...................................................................................... 123 Disscussion .......................................................................................................... 131 7. Impact and Future Directions .................................................................................. 137 Summary and impact of results ............................................................................ 137 Future directions ................................................................................................... 144 APPENDIX A. Model of Myofibroblast Differentiation ..................................................................... 148 B. Model Derivation for I-wire ...................................................................................... 166 REFERENCES ............................................................................................................ 180 v LIST OF TABLES Table Page 1.1 Vocabulary and Abbreviations ................................................................................... 7 3.1 Summary of integrin isoform expression in normal function and disease ................ 27 3.2 Summary of cadherin isoform expression in normal function and disease .............. 27 5.1 qPCR primers .......................................................................................................... 70 6.1 Model variables ..................................................................................................... 120 6.2 Passive mechanic metrics for control and isoproterenol-treated ECTCs ............... 124 vi LIST OF FIGURES Figure Page 1.1 Graphical overview of dissertation topic and aims..................................................... 5 2.1 Interplay between ECM stiffness and fibroblast phenotypes ................................... 10 2.2 Relevance of adhesion mechanobiology to fibrotic heart disease ........................... 14 2.3 Schematic of the stages in healing after myocardial infarction ................................ 19 3.1 Mechano-sensitive mechanisms of myofibroblast differentiation ............................. 23 3.2 Crosstalk between growth factor and adhesion protein signaling ............................ 32 4.1 Src and p38 are necessary for TGF-β1 induced myofibroblast differentiation ......... 42 4.2 Relevant signaling network ..................................................................................... 43 4.3 α-SMA is oppositely regulated by TGF-β1 and FGF2 through focal adhesion proteins and p38 and ERK dependent mechanisms ..................................................... 49 4.4 Different dynamic activation profiles for activation of ERK and p38 ........................ 51 4.5 α-SMA and cadherin-11 are not necessarily coexpressed ...................................... 53 4.6 α-SMA and cadherin-11 are sensitive to stiffness and the presence of FAK ........... 55 4.7 Expression of myofibroblast markers after treatment with TGF-β1 and FGF2 with GSK-3β inhibition .......................................................................................................... 56 5.1 Cadherin-11 is expressed after myocardial infarction .............................................. 73 5.2 Cadherin-11 null hearts respond differently after MI................................................ 75 5.3 Cadherin-11 blocking antibody treatment improves outcomes after MI ................... 77 5.4 SYN0012 reduces infarct remodeling and myofibroblast differentiation. ................. 79 5.5 SYN0012 effect on CF contractility .......................................................................... 80 5.6 Reduction of IL-6 observed 3 days post-MI in vivo with SYN0012 treatment .......... 82 vii 5.7 Reduction of F4/80 observed 3 days post-MI in vivo with SYN0012 treatment ....... 82 5.8 Transcriptional changes of inflammatory proteins after MI ...................................... 84 5.9 Transcriptional changes of pro-fibrotic proteins after MI .......................................... 85 5.10 Transcriptional changes of pro-angiogenic proteins after MI ................................. 87 5.11 Co-culture of macrophages and fibroblasts increase expression of IL-6 and MMP13 .......................................................................................................................... 89 5.12 Co-culture effects on other aspects of inflammatory/remodeling cascade ............ 90 5.13 Transcriptional changes of markers of macrophage polarization .......................... 92 5.14 Proposed cellular mechanisms of cadherin-11 in macrophages and fibroblasts . 101 5.15 Summary of results ............................................................................................. 103 6.1 Quantification of sarcomere length .......................................................................